Alpha 2.0
Login Register
» Authors » Massimiliano Missere

Massimiliano Missere

Explore the profile of Massimiliano Missere including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 21
Citations 226
Followers 0
Related Specialties
Radiology
Hematology
Cardiology & Vascular Diseases
Top 10 Co-Authors
Antonella Meloni
Vincenzo Positano
Alessia Pepe
Laura Pistoia
Liana Cuccia
Anna Spasiano
Maria Rita Gamberini
Riccardo Righi
Massimo Midiri
Paolo Ricchi
Published In
Rays
Am J Hematol
J Cardiovasc Magn Reson
Br J Haematol
J Magn Reson Imaging
Affiliations
Soon will be listed here.
Recent Articles
1.
Pancreatic Volume in Thalassemia: Determinants and Association with Alterations of Glucose Metabolism
Meloni A, Restaino G, Positano V, Pistoia L, Keilberg P, Santodirocco M, et al.
Diagnostics (Basel) . 2025 Mar; 15(5). PMID: 40075815
This study aimed to compare the pancreatic volume between beta-thalassemia major (β-TM) and beta-thalassemia intermedia (β-TI) patients and between thalassemia patients and healthy subjects and to determine the predictors of...
2.
Impact of the COVID-19 Pandemic on Iron Overload Assessment by MRI in Patients with Hemoglobinopathies: The E-MIOT Network Experience
Meloni A, Pistoia L, Lupi A, Righi R, Vallone A, Missere M, et al.
Tomography . 2023 Sep; 9(5):1711-1722. PMID: 37736989
Background: The E-MIOT (Extension-Myocardial Iron Overload in Thalassemia) project is an Italian Network assuring high-quality quantification of tissue iron overload by magnetic resonance imaging (MRI). We evaluated the impact of...
3.
The impact of HCV chronic positivity and clearance on extrahepatic morbidity in thalassemia major patients: an observational study from MIOT Network
Meloni A, Pistoia L, Gamberini M, Spasiano A, Cuccia L, Allo M, et al.
Eur J Intern Med . 2023 May; 114:93-100. PMID: 37150716
Background: No study has evaluated the effect of hepatitis C virus (HCV) infection on the wide spectrum of complications affecting patients with thalassemia. Objectives: This multicenter study prospectively assessed the...
4.
Left ventricular global function index is associated with myocardial iron overload and heart failure in thalassemia major patients
Meloni A, Positano V, Pistoia L, Righi R, Missere M, Grassedonio E, et al.
Int J Cardiovasc Imaging . 2023 Jan; 39(5):991-999. PMID: 36637709
Purpose: The left ventricular global function index (LVGFI) is a comprehensive marker of cardiac performance, integrating LV morphology with global function. We explored the cross-sectional association of LVGFI with myocardial...
5.
Quantitative T2* MRI for bone marrow iron overload: normal reference values and assessment in thalassemia major patients
Meloni A, Pistoia L, Restaino G, Missere M, Positano V, Spasiano A, et al.
Radiol Med . 2022 Sep; 127(11):1199-1208. PMID: 36087241
Purpose: We evaluated the feasibility and reproducibility of bone marrow T2* values and established the lower limit of normal in a cohort of healthy subjects. We investigated the clinical correlates...
6.
National networking in rare diseases and reduction of cardiac burden in thalassemia major
Pepe A, Pistoia L, Gamberini M, Cuccia L, Lisi R, Cecinati V, et al.
Eur Heart J . 2021 Dec; 43(26):2482-2492. PMID: 34907420
Aims: A tailored chelation therapy guided by magnetic resonance imaging (MRI) is a strategy to improve the prognosis in iron-loaded patients, in many cases still hampered by limited MRI availability....
7.
Genotypic groups as risk factors for cardiac magnetic resonance abnormalities and complications in thalassemia major: a large, multicentre study
Pistoia L, Meloni A, Ricchi P, Filosa A, Lisi R, Maggio A, et al.
Blood Transfus . 2020 Oct; 19(2):168-176. PMID: 33000750
Background: The causes and effects of genotypic heterogeneity in beta-thalassemia major (β-TM) have not been fully investigated. The aim of this multicentre study was to determine whether different genotype groups...
8.
Biventricular Reference Values by Body Surface Area, Age, and Gender in a Large Cohort of Well-Treated Thalassemia Major Patients Without Heart Damage Using a Multiparametric CMR Approach
Meloni A, Righi R, Missere M, Renne S, Schicchi N, Gamberini M, et al.
J Magn Reson Imaging . 2020 Apr; 53(1):61-70. PMID: 32311193
Background: Cardiac MRI plays a critical role in the management of thalassemic patients. No accurate biventricular reference values are available. Purpose: To establish the ranges for normal left ventricular (LV)...
9.
The effect of desferrioxamine chelation versus no therapy in patients with non transfusion-dependent thalassaemia: a multicenter prospective comparison from the MIOT network
Ricchi P, Meloni A, Pistoia L, Spasiano A, Spiga A, Allo M, et al.
Ann Hematol . 2018 Jun; 97(10):1925-1932. PMID: 29926157
We prospectively assessed by magnetic resonance imaging (MRI) the advantages of desferrioxamine (DFO) with respect to the absence of chelation therapy in non transfusion-dependent thalassaemia (NTDT) patients. We considered 18...
10.
Relationship between uric acid levels and cardiometabolic findings in a large cohort of β-thalassemia major patients
Vassalle C, Meloni A, Pistoia L, Gamberini M, Spasiano A, Gerardi C, et al.
Biomark Med . 2018 Mar; 12(4):341-348. PMID: 29569468
Aim: to evaluate the relationship between uric acid (UA), hepatic and cardiac iron overload (T2*-MRI), ferritin, endocrinological diseases and cardiac complications in a large thalassemia major (TM) cohort. Methods: A...